Opexa Announces Top-Line Results from Phase IIb Clinical Trial of ...
According to the study protocol, patients received a total of five subcutaneous injections at weeks 0, 4, 8, 12 and 24. The primary efficacy endpoint of the TERMS trial was the cumulative numb...